Post-Treatment Weight Gain While this isnt technically a side effect of the medication itself, one of the top concerns people have is regaining weight once they stop taking semaglutide
Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1
Molecular Metabolism , 15 , 3544
With retatrutide, this implies more than simply administering the drug
Key Takeaways Some patients may tolerate GLP-1 medications better with split dosing Smaller divided doses may reduce nausea, bloating, fatigue, and appetite swings in select individuals Twice-weekly dosing is generally considered off-label Not every patient benefits from dose splitting Long-term success depends on individualized care, nutrition, sleep, and strength training Patients should never change dosing schedules without provider guidance Splitting GLP-1 doses into twice-weekly injections is an off-label, occasionally helpful strategy for very sensitive patientsbut it is not an evidence-based standard for managing side effects